rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2005-3-4
|
pubmed:abstractText |
Resistance to clinically important antimicrobial agents, particularly fluoroquinolones and macrolides, is increasing among Campylobacter isolates, but few studies have explored the human health consequences of such resistance.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1899
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
191
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1050-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15747238-Adult,
pubmed-meshheading:15747238-Aged,
pubmed-meshheading:15747238-Anti-Bacterial Agents,
pubmed-meshheading:15747238-Campylobacter,
pubmed-meshheading:15747238-Campylobacter Infections,
pubmed-meshheading:15747238-Cohort Studies,
pubmed-meshheading:15747238-Denmark,
pubmed-meshheading:15747238-Drug Resistance, Bacterial,
pubmed-meshheading:15747238-Erythromycin,
pubmed-meshheading:15747238-Female,
pubmed-meshheading:15747238-Humans,
pubmed-meshheading:15747238-Infant,
pubmed-meshheading:15747238-Male,
pubmed-meshheading:15747238-Microbial Sensitivity Tests,
pubmed-meshheading:15747238-Middle Aged,
pubmed-meshheading:15747238-Quinolones,
pubmed-meshheading:15747238-Risk Factors,
pubmed-meshheading:15747238-Virulence
|
pubmed:year |
2005
|
pubmed:articleTitle |
Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study.
|
pubmed:affiliation |
Department of Epidemiology Research, Danish Epidemiology Science Centre, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|